Elevance Health, Inc. (ELV)
$394.30-$4.68 (-1.17%) Today
Gail Boudreaux - OfficerGail Boudreaux - Officer
Ronald W. Penczek - OfficerRonald W. Penczek - OfficerElevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 3 | 3,725 | $1.37M |
| Open-market sale | 2 | 520 | $209K |
50 Form 4 filings on record, the earliest from Oct 4, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Ramiro G. Peru - Director | Open-market purchase | Common Stock | 1,000 | $366.05 | $366K | |
| Gail Boudreaux - Officer | Open-market purchase | Common Stock | 680 | $366.41 | $249K | |
| Gail Boudreaux - Officer | Open-market purchase | Common Stock | 2,045 | $368.25 | $753K | |
| Ronald W. Penczek - Officer | Open-market sale | Common Stock | 369 | $403.16 | $149K | |
| Robert L. Dixon Jr. - Director | Open-market sale | Common Stock | 151 | $401.77 | $61K | |
| Ronald W. Penczek - Officer | Option exercise | Common Stock | 877 | $311.48 | $273K | |
| Ronald W. Penczek - Officer | Option exercise | Common Stock | 654 | $271.27 | $177K | |
| Ronald W. Penczek - Officer | Open-market sale | Common Stock | 1,531 | $403.13 | $617K | |
| Ronald W. Penczek - Officer | Option exercise | Employee Stock Option (Right to Buy) | 654 | $0.00 | - | |
| Ronald W. Penczek - Officer | Option exercise | Employee Stock Option (Right to Buy) | 877 | $0.00 | - | |
 Deanna D. Strable-Soethout - Director | Grant or award | Common Stock | 563 | $0.00 | - | |
| Amy W. Schulman - Director | Grant or award | Common Stock | 563 | $0.00 | - | |
| Ryan M. Schneider - Director | Grant or award | Common Stock | 563 | $0.00 | - | |
| Ramiro G. Peru - Director | Grant or award | Common Stock | 563 | $0.00 | - | |
| Antonio F. Neri - Director | Grant or award | Common Stock | 563 | $0.00 | - | |
| Bahija Jallal - Director | Grant or award | Common Stock | 563 | $0.00 | - | |
| Lewis Hay III - Director | Grant or award | Common Stock | 563 | $0.00 | - | |
| Robert L. Dixon Jr. - Director | Grant or award | Common Stock | 563 | $0.00 | - | |
 Susan D. Devore - Director | Grant or award | Common Stock | 563 | $0.00 | - | |
| Steven H. Collis - Director | Grant or award | Common Stock | 563 | $0.00 | - | |
| Amy W. Schulman - Director | Open-market sale | Common Stock | 26 | $287.50 | $7K | |
| Charles Morgan Kendrick Jr. - Officer | Open-market sale | Common Stock | 3,196 | $284.92 | $911K | |
| Steven H. Collis - Director | Open-market purchase | Common Stock | 3,000 | $289.84 | $870K | |
| Ronald W. Penczek - Officer | Grant or award | Common Stock | 426 | $0.00 | - | |
| Ronald W. Penczek - Officer | Grant or award | Common Stock | 1,701 | $0.00 | - | |
| Ronald W. Penczek - Officer | Grant or award | Common Stock | 266 | $0.00 | - | |
| Ronald W. Penczek - Officer | Tax withholding / forfeiture | Common Stock | 37 | $284.03 | $11K | |
| Ronald W. Penczek - Officer | Grant or award | Employee Stock Option (Right to Buy) | 1,677 | $0.00 | - | |
| Ronald W. Penczek - Officer | Tax withholding / forfeiture | Common Stock | 131 | $294.07 | $39K | |
| Erin M. Wessling - Officer | Grant or award | Common Stock | 2,976 | $0.00 | - | |
| Erin M. Wessling - Officer | Tax withholding / forfeiture | Common Stock | 417 | $284.03 | $118K | |
| Erin M. Wessling - Officer | Grant or award | Employee Stock Option (Right to Buy) | 11,754 | $0.00 | - | |
| Ryan R. Craig - Officer | Tax withholding / forfeiture | Common Stock | 309 | $284.03 | $88K | |
| Ryan R. Craig - Officer | Grant or award | Employee Stock Option (Right to Buy) | 11,754 | $0.00 | - | |
| Ryan R. Craig - Officer | Tax withholding / forfeiture | Common Stock | 25 | $294.07 | $7K | |
| Ryan R. Craig - Officer | Grant or award | Common Stock | 2,976 | $0.00 | - | |
 Felicia F. Norwood - Officer | Grant or award | Common Stock | 5,951 | $0.00 | - | |
| Felicia F. Norwood - Officer | Grant or award | Common Stock | 2,865 | $0.00 | - | |
| Felicia F. Norwood - Officer | Tax withholding / forfeiture | Common Stock | 496 | $284.03 | $141K | |
| Felicia F. Norwood - Officer | Grant or award | Employee Stock Option (Right to Buy) | 23,512 | $0.00 | - | |
| Felicia F. Norwood - Officer | Tax withholding / forfeiture | Common Stock | 1,421 | $294.07 | $418K | |
 Ratnakar Lavu - Officer | Grant or award | Employee Stock Option (Right to Buy) | 20,152 | $0.00 | - | |
| Ratnakar Lavu - Officer | Tax withholding / forfeiture | Common Stock | 315 | $294.07 | $93K | |
| Ratnakar Lavu - Officer | Grant or award | Common Stock | 5,101 | $0.00 | - | |
| Ratnakar Lavu - Officer | Grant or award | Common Stock | 6,802 | $0.00 | - | |
| Ratnakar Lavu - Officer | Tax withholding / forfeiture | Common Stock | 222 | $284.03 | $63K | |
| Charles Morgan Kendrick Jr. - Officer | Tax withholding / forfeiture | Common Stock | 467 | $284.03 | $133K | |
| Charles Morgan Kendrick Jr. - Officer | Grant or award | Employee Stock Option (Right to Buy) | 15,870 | $0.00 | - | |
| Charles Morgan Kendrick Jr. - Officer | Tax withholding / forfeiture | Common Stock | 1,211 | $294.07 | $356K | |
| Charles Morgan Kendrick Jr. - Officer | Grant or award | Common Stock | 4,017 | $0.00 | - | |
| Charles Morgan Kendrick Jr. - Officer | Grant or award | Common Stock | 2,532 | $0.00 | - | |
| Peter D. Haytaian - Officer | Tax withholding / forfeiture | Common Stock | 1,201 | $294.07 | $353K | |
| Peter D. Haytaian - Officer | Grant or award | Common Stock | 2,865 | $0.00 | - | |
| Peter D. Haytaian - Officer | Tax withholding / forfeiture | Common Stock | 446 | $284.03 | $127K | |
| Mark Kaye - Officer | Grant or award | Employee Stock Option (Right to Buy) | 25,188 | $0.00 | - | |
| Mark Kaye - Officer | Tax withholding / forfeiture | Common Stock | 271 | $294.07 | $80K | |
| Mark Kaye - Officer | Grant or award | Common Stock | 6,377 | $0.00 | - | |
| Mark Kaye - Officer | Grant or award | Common Stock | 10,202 | $0.00 | - | |
| Mark Kaye - Officer | Tax withholding / forfeiture | Common Stock | 353 | $284.03 | $100K | |
| Gail Boudreaux - Officer | Grant or award | Common Stock | 10,527 | $0.00 | - | |
| Gail Boudreaux - Officer | Tax withholding / forfeiture | Common Stock | 1,736 | $284.03 | $493K | |
| Gail Boudreaux - Officer | Grant or award | Employee Stock Option (Right to Buy) | 63,818 | $0.00 | - | |
| Gail Boudreaux - Officer | Tax withholding / forfeiture | Common Stock | 6,713 | $294.07 | $1.97M | |
| Gail Boudreaux - Officer | Grant or award | Common Stock | 16,153 | $0.00 | - | |
| Amy W. Schulman - Director | Grant or award | Common Stock | 218 | $0.00 | - | |
| Ryan R. Craig - Officer | Tax withholding / forfeiture | Common Stock | 279 | $341.83 | $95K | |
| Mark Kaye - Officer | Tax withholding / forfeiture | Common Stock | 2,895 | $340.24 | $985K |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - | View on EDGAR | |
| - | - | - | - | View on EDGAR |
Elevance Health, Inc. (ELV) had 4 insider filings in the last 90 days, with the most recent on 2026-07-17. The full record for ELV runs to 50 Form 4 filings, the earliest from 2024-10-04. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
3 insider purchases of ELV were filed in the last 90 days, totaling $1.37M.
2 insider sales of ELV were filed in the last 90 days, totaling $209K.
This page tracks ELV Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add ELV to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
